Long-term blockade of the renin–angiotensin system: an adequate evaluation is still needed

Blockade of the renin–angiotensin system (RAS) with an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB) is considered a possible tool, in combination with other therapies, for improving the outcome of patients at different stages of established cardiovascular disease (CVD) and for delaying the evolution of chronic… CONTINUE READING